BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 29908887)

  • 1. The Emerging Potential for Network Analysis to Inform Precision Cancer Medicine.
    Ozturk K; Dow M; Carlin DE; Bejar R; Carter H
    J Mol Biol; 2018 Sep; 430(18 Pt A):2875-2899. PubMed ID: 29908887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Lethal Networks for Precision Oncology: Promises and Pitfalls.
    Shen JP; Ideker T
    J Mol Biol; 2018 Sep; 430(18 Pt A):2900-2912. PubMed ID: 29932943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).
    Mateo J; Chakravarty D; Dienstmann R; Jezdic S; Gonzalez-Perez A; Lopez-Bigas N; Ng CKY; Bedard PL; Tortora G; Douillard JY; Van Allen EM; Schultz N; Swanton C; André F; Pusztai L
    Ann Oncol; 2018 Sep; 29(9):1895-1902. PubMed ID: 30137196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Art and Challenges of Precision Medicine: Interpreting and Integrating Genomic Data Into Clinical Practice.
    Madhavan S; Subramaniam S; Brown TD; Chen JL
    Am Soc Clin Oncol Educ Book; 2018 May; 38():546-553. PubMed ID: 30231369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical Methods for Establishing Personalized Treatment Rules in Oncology.
    Ma J; Hobbs BP; Stingo FC
    Biomed Res Int; 2015; 2015():670691. PubMed ID: 26446492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precision Medicine in Pediatric Oncology: Translating Genomic Discoveries into Optimized Therapies.
    Tran TH; Shah AT; Loh ML
    Clin Cancer Res; 2017 Sep; 23(18):5329-5338. PubMed ID: 28600472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining, Identifying, and Understanding "Exceptional Responders" in Oncology Using the Tools of Precision Medicine.
    Tsimberidou AM; Said R; Staudt LM; Conley BA; Takebe N
    Cancer J; 2019; 25(4):296-299. PubMed ID: 31335394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision Oncology Decision Support: Current Approaches and Strategies for the Future.
    Kurnit KC; Dumbrava EEI; Litzenburger B; Khotskaya YB; Johnson AM; Yap TA; Rodon J; Zeng J; Shufean MA; Bailey AM; Sánchez NS; Holla V; Mendelsohn J; Shaw KM; Bernstam EV; Mills GB; Meric-Bernstam F
    Clin Cancer Res; 2018 Jun; 24(12):2719-2731. PubMed ID: 29420224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Similarity Networks for Precision Medicine.
    Pai S; Bader GD
    J Mol Biol; 2018 Sep; 430(18 Pt A):2924-2938. PubMed ID: 29860027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision Medicine in Veterinary Science.
    Chon E; Hendricks W; White M; Rodrigues L; Haworth D; Post G
    Vet Clin North Am Small Anim Pract; 2024 May; 54(3):501-521. PubMed ID: 38212188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.
    Schmidt KT; Chau CH; Price DK; Figg WD
    J Clin Pharmacol; 2016 Dec; 56(12):1484-1499. PubMed ID: 27197880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision Oncology Beyond Genomics: The Future Is Here-It Is Just Not Evenly Distributed.
    Pfohl U; Pflaume A; Regenbrecht M; Finkler S; Graf Adelmann Q; Reinhard C; Regenbrecht CRA; Wedeken L
    Cells; 2021 Apr; 10(4):. PubMed ID: 33920536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matching cancer genomes to established cell lines for personalized oncology.
    Dudley JT; Chen R; Butte AJ
    Pac Symp Biocomput; 2011; ():243-52. PubMed ID: 21121052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing the European Society for Medical Oncology Scale for Clinical Actionability of Molecular Targets in a Comprehensive Profiling Program: Impact on Precision Medicine Oncology.
    Martin-Romano P; Mezquita L; Hollebecque A; Lacroix L; Rouleau E; Gazzah A; Bahleda R; Planchard D; Varga A; Baldini C; Postel-Vinay S; Friboulet L; Loriot Y; Verlingue L; Geraud A; Camus MN; Nicotra C; Soria JC; André F; Besse B; Massard C; Italiano A
    JCO Precis Oncol; 2022 Oct; 6():e2100484. PubMed ID: 36315916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated patient and tumor genetic testing for individualized cancer therapy.
    Hertz DL; McLeod HL
    Clin Pharmacol Ther; 2016 Feb; 99(2):143-6. PubMed ID: 26537014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-Generation Sequencing for Advanced Breast Cancer: What the Way to Go?
    Trapani D; Crimini E; Sandoval J; Curigliano G
    Cancer Treat Res; 2023; 188():343-351. PubMed ID: 38175352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network science in clinical trials: A patient-centered approach.
    Manem VSK; Salgado R; Aftimos P; Sotiriou C; Haibe-Kains B
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):135-150. PubMed ID: 29278737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Precision medicine in oncology].
    Mack E
    Inn Med (Heidelb); 2024 Mar; 65(3):194-201. PubMed ID: 37921995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RDF SKETCH MAPS - KNOWLEDGE COMPLEXITY REDUCTION FOR PRECISION MEDICINE ANALYTICS.
    Thanintorn N; Wang J; Ersoy I; Al-Taie Z; Jiang Y; Wang D; Verma M; Joshi T; Hammer R; Xu D; Shin D
    Pac Symp Biocomput; 2016; 21():417-28. PubMed ID: 26776205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.
    Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y
    Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.